-
br Preparation of NiFe O NTs Envision Ab
2020-08-12
2.5. Preparation of NiFe2O4 NTs/Envision-Ab1 hybrids In brief, 80 μL 4.2 μg/mL Ab1 was activated with 40 μL EDC/NHS (molar ratio 4:1) for 40 min at 4 °C. Then the above solution was mixed with 80 μL of Envision complex and reacted for 50 min to realize the amide reaction between Envision comple
-
br aPKC mediated ROS inhibition enhances gemcitabine resista
2020-08-12
3.5. aPKCι-mediated ROS inhibition enhances gemcitabine resistance in GBC Next, we further investigated whether aPKCι would influence the sensitivity of GBC Celacol HPM 5000 to commonly used chemotherapeutic drugs gemcitabine. Given that ROS has been reported to participate in che-moresistance
-
HG 9 91 01 br our study we did not
2020-08-12
our study, we did not observe cytotoxic effects of apatinib on ovarian cancer cells. The inhibitory mechanism of apatinib in ovarian cancer cells was further investigated by detecting changes in the cell cycle and cell apoptosis. But, in our study, apatinib did not alter the ovarian cancer cell
-
br b UCLA Department of Chemistry and Bi http www
2020-08-12
b UCLA Department of Chemistry and Biochemistry, Los Angeles CA 90095, USA c UCLA Department of Surgery, Division of Surgical Oncology, Los Angeles CA 90095, USA e UCLA Jonsson Comprehensive Cancer Center, Los Angeles CA 90095, USA Keywords: Selective estrogen receptor downregulator
-
Data information In A B C
2020-08-12
Data information: In A, B, C, and D, data represent mean ± SEM (n = 6); *P < .05 or **P < .01. quantified by the RayBio® Analysis Tool software. Subcutaneous tumor xenograft models were built to evaluate the anti-tumor effect of Mar-C on A549 57186-25-1 in vivo. Balb/c athymic (nu +/nu+) fema
-
br McCarthy DM Maitra A Argani P et
2020-08-12
7. McCarthy DM, Maitra A, Argani P et al. Novel markers of pancreatic adenocarcinoma in fine-needle aspiration: mesothelin and prostate stem cell antigen labeling increases accuracy in cytologically borderline cases. Appl Immunohistochem Mol Morphol 2003; 11: 238 – 43. 8. Fritcher EG, Kipp BR,
-
br Modulation of alternative pre
2020-08-12
Modulation of alternative pre-mRNA splicing with ceramide allows Biochemical Pharmacology 160 (2019) 134–145 cancer WAY 316606 to express pro-apoptotic isoforms of BCL-x and caspase-9 [25,26], and even to restore wt p53 levels and functions in cancer cells carrying a p53-deletion mutation [
-
br ACCEPTED MANUSCRIPT br Another interesting approach to en
2020-08-07
ACCEPTED MANUSCRIPT Another interesting approach to enhancing anti-PD-1 therapies has been the use of PD-1 receptor-expressing nanovesicle decoys88. Cellular membranes can be engineered into nanoscale vesicles using a membrane extrusion method. One group generated nanovesicles with high levels
-
br Introduction br Recently paclitaxel PTX preparations whic
2020-08-07
1. Introduction Recently, paclitaxel (PTX) preparations, which are effective for the treatment of various tumors such as breast cancer, non-small cell lung cancer, and ovarian cancer have been widely used and studied [1,2]. This anticancer agent exerts a tumor effect by polymerizing tubulin monom
-
br of these times confirmed
2020-08-07
of these times confirmed that the peak in the sample (BHAE) is corre-sponding to the berberine. The content of berberine in the BHAE was de-termined from the area of the chromatogram, to be 3.30 mg in 100 mg of total alkaloids (i.e., 3.30% weight by weight of alkaloids) with devia-tion less than 1
-
br Finally prior screening i e never
2020-08-06
Finally, prior screening (i.e., never screened vs. screened) was examined in relation to the number and type of screening barriers and facilitators listed by women. In the first analysis, the number of prac-tical and psychological screening barriers listed by women was related to prior screenin
-
br Margins br Negative br Positive br Extraprostatic br Exte
2020-08-06
Margins Negative Positive Extraprostatic Extension Negative Positive Seminal Vesicle Invasion Negative Positive Lymph Node Metastasis Negative Positive CAPRA-S Risk Category Low Intermediate High Adverse Pathologya No Yes Data
-
br Contents lists available at ScienceDirect br
2020-08-04
Contents lists available at ScienceDirect International Journal of Pharmaceutics journal homepage: www.elsevier.com/locate/ijpharm AS1411 derivatives as carriers of G-quadruplex ligands for cervical cancer T cells Joana Figueiredoa,1, Jéssica Lopes-Nunesa,1, Josué Carvalhoa,1, Francis
-
br Fig Isotherm and pore distribution curves of a
2020-08-02
Fig. 8. Isotherm and pore distribution curves of a) [email protected] and b) [email protected]@L-Dopa based on the BET and BJH method, respectively. Finally, the forth mass loss step in temperature above 570 °C is probably due to the decomposition of the mixed metal oxide into a spinel phase [33].
-
br The present study employed the tumor
2020-07-31
The present study employed the tumor sphere formation culture for three generations to characterize the CSCs of MCF-7 and MDA-MB- 231 cells. Cells with CD44+CD24−/low surface markers were highly enriched for stem-like mammospheres when compared with the same type of adherent cells. Flow cytomet